Navigation Links
YM BioSciences third quarter 2010 operational and financial results
Date:5/13/2010

ch (AACR) Annual Meeting held on April 17-21 in Washington, DC. - Presented posters on CYT387 and CYT997, the Company's novel vascular disrupting agent, at the Lorne Cancer Conference in Lorne, Victoria, Australia. - Published pivotal preclinical data for CYT387 as a First Edition in the premier hematology journal Blood. - Had granted two additional patents in the US for AeroLEF(R), our proprietary, inhaled-delivery composition of free and liposome- encapsulated fentanyl for the treatment of moderate to severe acute pain. - Reported positive results on the selective activity of a highly potent antibody-radionuclide with nimotuzumab in breast cancer cells resulting from a collaboration with researchers at the University of Toronto. - Appointed Rogerio C. Lilenbaum, M.D., M. Sc., Minesh Mehta, M.D., and Roman Perez-Soler, M.D., together with two additional leading US oncologists have to a US Consultative Committee to YM on the ongoing development YM's anti-cancer products. - Closed registered direct offering for gross proceeds of approximately US $17.5 million.

Subsequent to the quarter end, the Company initiated an "At-The-Market" financing facility for up to 7.5 million common shares.

"The substantial liquidity in our share trading permits us to access this innovative financing mechanism which will provide us with important flexibility in the timing of any future financing and, if implemented, should significantly reduce our overall cost of capital," said Mr. Allan. "This established mechanism has been used across multiple industries by numerous companies including several life-sciences companies and is designed to result in the issuance of shares at no discount to the quoted market at the time of a transaction. We are not required to sell any shar
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
2. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
3. YM BioSciences announces controlled equity offering
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
5. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
9. YM BioSciences closes US$17.5 million financing
10. YM BioSciences to raise approximately US$15 million
11. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... as aids to weight loss and diabetes prevention, could ... disease; and they do it in a surprising way: ... microbiota the substantial population of bacteria residing in ... mice and humans, were published today in Nature ... the Weizmann Institute,s Immunology Department, who led this research ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Pipette.com ... include Sartorius/Biohit, Socorex, Capp, and AccuPet brand of ... of 100 uL or less and are a ... forensic applications. , The micropipette promotions were ... and economic alternative products to help customers find ...
(Date:9/17/2014)... 2014 The global consumption of squalene / squalane ... a natural skin-identical chemical that finds applications in various end ... pharmaceuticals, and in other applications like high grade lubrication, and ... few major players and is regionally segregated. Sophim ( ... Co. Ltd. ( Japan ), SeaDragon Marine Oils ...
(Date:9/17/2014)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), ... protected regenerative biomaterials and bioimplants processed from human ... clinical study.    The study article, ... Trial Evaluating the Use of Dehydrated ... Therapy vs. Multi-layer Compression Therapy Alone in the ...
Breaking Biology Technology:Gut bacteria, artificial sweeteners and glucose intolerance 2Gut bacteria, artificial sweeteners and glucose intolerance 3Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4
... Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH), ... be participating in the Wachovia Securities 2008 Healthcare,Conference in ... Time., A live webcast of the presentation can ... . The webcast will,be archived for replay following the ...
... WILMINGTON, N.C., Jan. 23 PPD, Inc. (Nasdaq:,PPDI) ... central lab services,into China through an exclusive agreement ... agreement allows PPD to begin,immediately providing biopharmaceutical clients ... services in China., "Chinese law makes it ...
... Represent Association of Family Cord Blood Banks, ... Services, a,subsidiary of California Cryobank, today announced that ... has been appointed to the Department,of Health and ... Advisory Council on Blood Stem Cell Transplantation,(ACBSCT). Through ...
Cached Biology Technology:PPD Expands Global Central Lab Services into China 2PPD Expands Global Central Lab Services into China 3Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 2Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 3
(Date:9/17/2014)... to reproductive technologies, the justice and well-being of ... to identify key issues, articulate their values and ... most defensible ways forward. But what are the ... The Hastings Center and the Presidential Commission for ... to publish a series of essays to highlight ...
(Date:9/17/2014)... 17, 2014) A rare genetic disorder known as Jacobsen ... recent joint investigation by researchers at San Diego State ... addition to suggesting better treatment options for people with ... the genetic underpinnings of autism., Jacobsen syndrome affects approximately ... of Health. It occurs in a person when there ...
(Date:9/17/2014)... researchers have obtained the first partial genome sequence of ... found at the site of the Montsoriu Castle in ... is closely related to today,s Iberian pig. Researchers also ... modern Iberian pigs. , The study, published in ... pig species, and particularly on that of the Iberian ...
Breaking Biology News(10 mins):Why bioethics literacy matters 2Why bioethics literacy matters 3A link between Jacobsen syndrome and autism 2Iberian pig genome remains unchanged after 5 centuries 2
... from Virginia Tech and Molsoft LLC have received ... Institute of Allergy and Infectious Diseases (NIAID) to ... of resistance-breaking insecticides to reduce malaria transmission. ... the malaria mosquito in sub-Saharan African is insecticide ...
... damage, for example as a result of exposure to ionizing ... damage or program themselves for death, a process called apoptosis. ... as it is remarkable, involving what might be described metaphorically ... DNA packed tightly in the cell nucleus. In intricate ...
... APRIL 9, 2009 -- Four experts in soil carbon ... farmers and foresters have to manage soil carbon to ... Agricultural and forest soils in the U.S. have the ... dioxide (CO 2 ) every year, offsetting up to ...
Cached Biology News:NIH funds development of resistance-breaking insecticides to reduce malaria transmission 2NIH funds development of resistance-breaking insecticides to reduce malaria transmission 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 2CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 4Down to Earth carbon science: Briefing April 15 in DC 2
... Hybrid-Ready Tissues are selected tissues from ... been fixed, embedded in paraffin, sectioned and ... the slides are ready for use in ... The Hybrid-Ready tissue slides are suitable for ...
...
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
Immunochemistry 1 & 2...
Biology Products: